Super Current Affairs

Polity

Drugs Rules, 1945: Proposed Schedule M Flexibility for Three Drug Categories

19 November 20263 min1 source4 questionsStory 28 of 42

Tags:Polity

Full backgroundEverything covered at a glance

Source:PIBPIB

Subject: Governance, Health Sector Regulation (Drugs and Pharmaceutical Quality Control)

Key points for Prelims: Schedule M (Good Manufacturing Practices), Drugs Technical Advisory Board (DTAB), Drugs Rules, 1945, Medicinal gases, Empty gelatin capsules, Disinfectant fluids

Mains syllabus mapping

  • General Studies Paper 2: Health, Government policies and interventions, Regulatory bodies and quality control of drugs
  • General Studies Paper 3: Industrial policy, Pharmaceutical sector regulation, Ease of doing business and regulatory reform

Drugs and Cosmetics Rules, 1945 (proposed incorporation of Good Storage and Distribution Practices): quick facts

Parent law
Drugs and Cosmetics Act, 1940; the Rules of 1945 implement this Act
Guidance source
GSDP guidance developed by the Central Drugs Standard Control Organisation (CDSCO)
Scope of GSDP
Procurement, purchasing, storage, distribution, transportation, documentation and record-keeping

Key facts for one-day exams

  • The proposed amendment concerns the Drugs Rules, 1945.
  • The draft notification is numbered G.S.R. 985(E).
  • Revised Schedule M was notified on 28 December 2023.
  • The Drugs Technical Advisory Board considered the issue at its 93rd meeting.
  • The three categories include medicinal gases, empty gelatin capsules and disinfectant fluids.

Drugs Rules 1945 Schedule M amendment: why in the news?

The Ministry of Health and Family Welfare has published a draft amendment to the Drugs Rules, 1945, proposing continued Schedule M exemptions for medicinal gases, empty gelatin capsules and disinfectant fluids, based on a DTAB recommendation. The move matters because it seeks product-specific regulatory flexibility without removing quality and safety requirements.

The Union Ministry of Health and Family Welfare has proposed an amendment to the Drugs Rules, 1945, through a draft Gazette Notification G.S.R. 985(E) dated 6 November 2026, to provide regulatory flexibility under the revised Schedule M for medicinal gases, empty gelatin capsules and disinfectant fluids. The proposal follows representations from stakeholders who raised concerns about the applicability of certain provisions of the revised Schedule M, which was notified vide G.S.R. 922(E) on 28 December 2023, to these product categories.

The matter was examined by the Drugs Technical Advisory Board (DTAB) during its 93rd meeting held on 16 February 2026. The Board observed that some requirements under the revised Schedule M may not be relevant to the manufacturing processes of these three categories and recommended continuing the exemptions that were available to them under Schedule M before its revision. The proposed amendment does not dilute applicable quality, safety or regulatory oversight standards, but aims to align regulatory requirements with the nature of the products while allowing Licensing Authorities to take product-specific decisions based on scientific and practical considerations.

Stakeholders and members of the public are invited to submit objections and suggestions within the prescribed period from the date of publication of the draft notification in the Official Gazette. Comments may be addressed to the Under Secretary (Drugs), Ministry of Health and Family Welfare, or sent via email.

Key features and how it works

  • The Rules classify drugs into schedules (for example Schedule H, H1 and X) and set rules for storage, sale, display and prescription of each schedule.
  • GSDP requirements would cover procurement, purchasing, storage, distribution, transportation, documentation and record-keeping across the supply chain.PIB
  • Incorporating GSDP into the Rules would make the guidelines legally binding and give Central and State drug-control authorities a basis for inspection and enforcement.
  • The framework seeks to improve documentation, record-keeping and traceability, and to make manufacturers, importers, wholesalers, distributors and stockists accountable.PIB

Related Static GK and comparison

  • CDSCO is responsible for drug approvals, clinical trials, drug standards, imported drug quality control and coordination of State Drug Control Organisations.cdsco.gov.in
  • Drugs Controller General of India (DCGI): head of the CDSCO, responsible for approval of licences for specified drug categories such as blood and blood products, IV fluids, vaccines and sera, and for setting standards for manufacturing, sale, import and distribution of drugs.
  • Drugs and Cosmetics Act, 1940: the parent law that regulates import, manufacture and distribution of drugs in India; originally called the Drug Act and passed in 1940 on the recommendations of the Chopra Committee; the Rules of 1945 were made under it.
  • Schedule H1 (notified in 2013): covers third and fourth generation antibiotics, some psychotropic drugs and anti-TB drugs; a separate register must be kept for their supply.
  • Schedule X lists addictive drugs such as narcotics and psychotropics that have medicinal uses and must be kept under lock and key. Schedule H regulations also apply.

Achievements

  • The proposal would incorporate GSDP guidelines into the Drugs Rules, 1945, building on CDSCO guidance.PIB
  • Clear coverage of the full supply chain, from manufacturer or importer to the patient, makes responsibility easier to assign at each stage.
  • The proposed framework would promote documentation, record-keeping and traceability.PIB

Challenges

  1. Enforcement depends on State drug-control authorities, so uneven capacity across States may affect uniform implementation.
  2. India's drug-regulatory framework has been criticised for lax laws, exploitable loopholes and inadequate enforcement.
  3. Smaller wholesalers and stockists may find new documentation and storage requirements costly to meet.

Way forward

  • Monitor outcomes through regular inspection data from Central and State drug-control authorities.
  • Provide handholding and guidance to small distributors and stockists to meet the new storage and record-keeping norms.
  • Converge GSDP enforcement with the existing schedule-based controls and the CDSCO's inspection network.

Connected to this news

Drugs and Cosmetics Rules, 1945 (proposed incorporation of Good Storage and Distribution Practices)

The Drugs and Cosmetics Rules, 1945 are the implementing rules of the Drugs and Cosmetics Act, 1940, and the Centre has proposed adding Good Storage and Distribution Practices (GSDP) to them so that supply-chain storage and distribution norms become legally binding.

Timeline

  1. 19 November 2026

    Health Ministry proposed incorporating GSDP guidelines (covering storage, distribution and record-keeping of drugs) into the Drugs Rules, 1945, making them legally binding; stakeholders invited to send objections and suggestions.

    Read the story
  2. 19 November 2026

    Draft notification G.S.R. 987(E) proposes separate licensing for bulk drug wholesale under the Drugs Rules, 1945, using new Forms 19-BC and 20-BC, with existing licensees given time to comply.

    Read the story
  3. 19 November 2026This story

    Health Ministry published a draft amendment to the Drugs Rules, 1945, proposing continued Schedule M exemptions for medicinal gases, empty gelatin capsules and disinfectant fluids, based on a DTAB recommendation, open for public objections.

  4. 8 September 2026

    Draft notification G.S.R. 791(E) proposed mandatory CCTV at retail premises selling Schedule H, H1 and X drugs; not yet in force as of September 2026.

  5. 2013

    Schedule H1 notified.

  6. 1945

    Drugs and Cosmetics Rules, 1945 made to implement the Act.

See the full timeline (7 events)
Read the full background

Key terms

Schedule M:
Schedule M is part of the Drugs Rules, 1945 and sets requirements related to good manufacturing practices for pharmaceutical products.
Good manufacturing practices:
Good manufacturing practices are standards and procedures intended to help ensure that products are consistently manufactured and controlled for quality.
Draft notification:
A draft notification states a proposed regulatory change before its finalisation and may invite public comments.

Drugs Rules 1945 Schedule M amendment: why it matters for exams

Syllabus: Governance: Regulation and public consultation; Society: Public health and drug safety

Common mistake: Examiners may present the draft amendment as a final exemption from all quality standards; it is a proposal to continue earlier exemptions while retaining applicable quality and safety requirements.

Mains practice questions

Question 1(GS-2 | 250 words | 15 marks)

Critically examine the proposed amendment to the Drugs Rules, 1945 that seeks product-specific flexibility under the revised Schedule M for medicinal gases, empty gelatin capsules and disinfectant fluids. Does such calibrated regulatory relief strengthen or weaken India's drug quality framework?

Answer outline

  • Introduction: Open by noting that the draft notification G.S.R. 985(E) reflects a DTAB recommendation to restore earlier exemptions for three product categories, raising the question of whether regulatory flexibility can coexist with quality assurance.
  • Body:
    • Explain Schedule M as the Good Manufacturing Practice standard under the Drugs Rules, 1945, and why the revised version (G.S.R. 922(E), 2023) created compliance difficulties for certain product categories.
    • Argue the case for flexibility: requirements may not match the manufacturing realities of medicinal gases, empty gelatin capsules and disinfectant fluids, and stakeholder representations and DTAB review give the decision a technical basis.
    • Argue the concern: exemptions can create regulatory gaps, and the government's assurance that quality, safety and oversight standards are not diluted must be verified through transparent implementation.
    • Note the role of Licensing Authorities in taking product-specific decisions, which balances uniform standards with scientific judgement but also raises questions of consistency across states.
    • Suggest safeguards such as periodic review, inspection mechanisms and public consultation, which the open objection window partly provides.
  • Conclusion: A balanced approach would treat calibrated exemptions as legitimate only when backed by scientific rationale, transparent consultation and continued enforcement, so that ease of compliance does not compromise patient safety.

Question 2(GS-2 | 150 words | 10 marks)

Discuss the role of stakeholder consultation and expert advisory bodies such as the Drugs Technical Advisory Board in making subordinate regulations in India's health sector. What lessons does the Schedule M amendment process offer for regulatory governance?

Answer outline

  • Introduction: Frame the answer around the process: stakeholder representations led to DTAB review and a draft notification open for public objections, illustrating participatory rule-making.
  • Body:
    • Describe the advisory role of the DTAB, which provides technical expertise that informs amendments under the Drugs Rules, 1945.
    • Highlight the value of public objections and suggestions in improving transparency and accountability of delegated legislation.
    • Point out limitations such as technical jargon limiting meaningful public participation and the need for timely, reasoned responses to comments.
  • Conclusion: Expert-led, consultative rule-making enhances regulatory legitimacy, and its success depends on how seriously the government engages with the feedback it receives.

Stuck? Get it in one tap

Practice questions

Pick an answer, then read the explanation.

  1. Q1Easy

    Which ministry proposed the amendment to the Drugs Rules, 1945 concerning medicinal gases, empty gelatin capsules and disinfectant fluids?

  2. Q2Hard

    Consider the following statements about the proposed Schedule M amendment in 2026:

    • 1. It seeks to continue exemptions available before the revision of Schedule M.
    • 2. It covers medicinal gases, empty gelatin capsules and disinfectant fluids.
    • 3. It removes all applicable quality and safety requirements for these categories.

    Which of the statements given above is/are correct?

  3. Q3Medium

    On what date did the Drugs Technical Advisory Board hold its 93rd meeting concerning the Schedule M exemptions?

  4. Q4Medium

    What is the primary objective of the proposed Schedule M amendment for medicinal gases, empty gelatin capsules and disinfectant fluids?

Frequently asked questions

1. Which products are covered by the proposed Schedule M amendment?

The proposal covers medicinal gases, empty gelatin capsules and disinfectant fluids.

2. What did the Drugs Technical Advisory Board recommend for Schedule M?

The board recommended continuing exemptions available to the three categories before the revision of Schedule M.

3. Does the proposed Schedule M amendment remove quality standards?

No. Applicable quality and safety requirements and regulatory oversight would continue.

4. When was the draft notification for the Drugs Rules amendment dated?

Draft Gazette Notification G.S.R. 985(E) is dated 6 November 2026.

All sources

Stories from the last 30 days on the same topic, state or exams

Health & EducationUPSC: Important

Proposed Schedule M amendment to align Grade A microbial limits with WHO

  • Nodal Ministry: Ministry of Health and Family Welfare
  • Parent Rule: Drugs Rules, 1945
Background GK: Schedule M (Drugs Rules, 1945)Drugs Rules, 1945, Schedule MNodal: Ministry of Health and Family WelfareDon't make this mistake!
4 questions · 2 minPIB